DTIL

PRECISION BIOSCIENCES INC

Biological Products, (No Diagnostic Substances)NasdaqNon-accelerated filer<br>Smaller reporting company

Total Trades

92

Buys

19

Sells

36

Largest Trade

N/A

Insiders

10

Institutional Funds

47

Inst. Value

$1M+

Activist Filings

37

Insider Trades

InsiderTitleTypeValueSharesPriceDate
Amoroso MichaelPresident and CEOEXERCISEN/A115KJan 22, 2026
Amoroso MichaelPresident and CEOSELL$100K–$500K35K$4.17Jan 22, 2026
Scimeca DarioGeneral Counsel an…SELL$15K–$50K9K$4.03Jan 22, 2026
Scimeca DarioGeneral Counsel an…EXERCISEN/A25KJan 22, 2026
Kelly John AlexanderCFOSELL$50K–$100K15K$4.03Jan 22, 2026
Kelly John AlexanderCFOEXERCISEN/A44KJan 22, 2026
SMITH J. JEFFERSONChief Research Off…EXERCISEN/A29KJan 22, 2026
SMITH J. JEFFERSONChief Research Off…SELL$15K–$50K10K$4.03Jan 22, 2026
Germano Geno JDirectorBUY$1K–$15K3K$4.72Dec 17, 2025
Frankel StanleyDirectorBUY$1K–$15K3K$4.70Dec 17, 2025
Brown MelindaDirectorBUY$1K–$15K1K$4.97Dec 17, 2025
Kelly John AlexanderCFOSELL$1K–$15K1K$6.49Nov 4, 2025
Kelly John AlexanderCFOEXERCISEN/A4KNov 4, 2025
Scimeca DarioGeneral Counsel an…SELL$1K–$15K665$6.49Nov 4, 2025
Scimeca DarioGeneral Counsel an…EXERCISEN/A2KNov 4, 2025
Amoroso MichaelPresident and CEOEXERCISEN/A9KNov 4, 2025
Amoroso MichaelPresident and CEOSELL$15K–$50K3K$6.49Nov 4, 2025
Frankel StanleyDirectorBUY$1K–$15K3K$4.97Sep 30, 2025
Brown MelindaDirectorBUY$1K–$15K1K$4.89Sep 24, 2025
Kelly John AlexanderCFOSELL$50K–$100K15K$4.26Jul 8, 2025
Brown MelindaDirectorBUY$1K–$15K2K$4.14Jun 27, 2025
Buehler KevinDirectorBUY$15K–$50K5K$4.16Jun 27, 2025
Buehler KevinDirectorBUY$15K–$50K5K$4.67Mar 28, 2025
Brown MelindaDirectorBUY$1K–$15K2K$4.75Mar 28, 2025
Germano Geno JDirectorBUY$15K–$50K3K$5.30Mar 27, 2025
Amoroso MichaelPresident and CEOSELL$1K–$15K964$5.56Mar 25, 2025
Amoroso MichaelPresident and CEOEXERCISEN/A3KMar 25, 2025
Scimeca DarioGeneral Counsel an…SELL$15K–$50K9K$4.79Jan 23, 2025
Scimeca DarioGeneral Counsel an…EXERCISEN/A25KJan 23, 2025
Amoroso MichaelPresident and CEOSELL$100K–$500K37K$4.67Jan 23, 2025
Amoroso MichaelPresident and CEOEXERCISEN/A115KJan 23, 2025
SMITH J. JEFFERSONChief Research Off…EXERCISEN/A29KJan 23, 2025
SMITH J. JEFFERSONChief Research Off…SELL$15K–$50K10K$4.79Jan 23, 2025
Germano Geno JDirectorBUY$15K–$50K4K$4.49Jan 2, 2025
Buehler KevinDirectorBUY$15K–$50K4K$4.88Dec 31, 2024
Kelly John AlexanderCFOBUY$1K–$15K2K$4.75Dec 31, 2024
Brown MelindaDirectorBUY$1K–$15K3K$4.55Dec 30, 2024
Kelly John AlexanderCFOBUY$15K–$50K3K$6.76Nov 21, 2024
Scimeca DarioGeneral Counsel an…SELL$1K–$15K588$8.19Nov 6, 2024
Scimeca DarioGeneral Counsel an…EXERCISEN/A2KNov 6, 2024
Amoroso MichaelPresident and CEOSELL$15K–$50K3K$8.19Nov 6, 2024
Amoroso MichaelPresident and CEOEXERCISEN/A9KNov 6, 2024
Scimeca DarioGeneral Counsel an…EXERCISEN/A301Jun 11, 2024
Scimeca DarioGeneral Counsel an…SELL$1K–$15K93$11.79Jun 11, 2024
SMITH J. JEFFERSONChief Research Off…EXERCISEN/A163Jun 11, 2024
SMITH J. JEFFERSONChief Research Off…SELL<$1K50$11.79Jun 11, 2024
Scimeca DarioGeneral Counsel an…EXERCISEN/A918May 3, 2024
Scimeca DarioGeneral Counsel an…SELL$1K–$15K272$10.32May 3, 2024
SMITH J. JEFFERSONChief Research Off…SELL$1K–$15K154$10.32May 3, 2024
SMITH J. JEFFERSONChief Research Off…EXERCISEN/A519May 3, 2024
🔓Seeing ranges? Sign in for exact trade values — free forever

Institutional Ownership

13F filings as of Dec 31, 2025 · 47 funds holding

Activist & 5%+ Owners

SC 13D/13G filings — investors holding 5%+ of outstanding shares

TANG CAPITAL MANAGEMENT, LLC

SC 13G/A · Feb 17, 2026

0.0%

0 shares

Lynx1 Capital Management LP

SC 13G/A · Feb 17, 2026

4.1%

994K shares

Bleichroeder LP

SC 13G/A · Feb 13, 2026

8.2%

1.9M shares

Octagon Capital Advisors LP

SC 13G · Feb 10, 2026

10.0%

2.3M shares

Aberdeen Group plc

SC 13G · Jan 27, 2026

8.9%

2.1M shares

Empery Asset Management, LP

SC 13G · Jan 22, 2026

10.0%

2.3M shares

LYNX1 CAPITAL MANAGEMENT LP

SC 13G/A · Nov 14, 2025

8.8%

1.0M shares

Readout Capital, LP

SC 13G/A · Aug 14, 2025

9.3%

1.1M shares

Bleichroeder LP

SC 13G · Aug 14, 2025

9.7%

1.1M shares

Aquilo Capital, L.P.

SC 13G/A · Aug 6, 2025

0.0%

0 shares

Novartis Pharma AG

SC 13G/A · Aug 6, 2025

3.7%

414K shares

TANG CAPITAL MANAGEMENT, LLC

SC 13G/A · May 15, 2025

6.4%

673K shares

Highbridge Capital Management, LLC

SC 13G/A · Apr 25, 2025

3.7%

406K shares

Readout Capital, LP

SC 13G · Mar 26, 2025

8.8%

920K shares

Weinstein Benjamin

SC 13G · Mar 18, 2025

5.2%

395K shares

Aquilo Capital, L.P.

SC 13G/A · Feb 14, 2025

6.6%

521K shares

JANUS HENDERSON GROUP PLC

SC 13G/A · Feb 14, 2025

0.0%

0 shares

Lynx1 Capital Management LP

SC 13G · Feb 14, 2025

10.0%

766K shares

Novartis Pharma AG

SC 13G/A · Feb 12, 2025

5.4%

414K shares

Perceptive Advisors LLC

SC 13G/A · Nov 14, 2024

5.9%

426K shares

Tang Capital Management, LLC

SC 13G/A · Nov 14, 2024

8.6%

623K shares

9.7%

702K shares

5.3%

406K shares

Aquilo Capital, L.P.

SC 13G · Mar 18, 2024

7.1%

467K shares

Perceptive Advisors LLC

SC 13G · Mar 14, 2024

7.9%

500K shares

8.0%

511K shares

Great Point Partners, LLC

SC 13G/A · Feb 14, 2024

0.0%

0 shares

Capital World Investors 95-1411037

SC 13G/A · Feb 12, 2024

4.2%

5.1M shares

Great Point Partners, LLC

SC 13G · Feb 27, 2023

7.3%

8.1M shares

Great Point Partners, LLC

SC 13G/A · Feb 14, 2023

3.4%

3.8M shares

Capital World Investors 95-1411037

SC 13G/A · Feb 13, 2023

6.1%

6.7M shares

Eli Lilly and Company 35-0470950

SC 13G/A · Jan 27, 2023

3.4%

3.8M shares

Derek Jantz

SC 13G/A · Aug 31, 2022

3.9%

4.3M shares

BlackRock, Inc.

SC 13G · Jul 8, 2022

2.4%

2.4M shares

Great Point Partners, LLC

SC 13G · Jul 1, 2022

5.9%

5.8M shares

Novartis Pharma AG

SC 13G · Jun 27, 2022

16.6%

12.4M shares

Capital World Investors 95-1411037

SC 13G/A · Feb 11, 2022

7.0%

4.3M shares

View on Google Finance →